Treating a cancerous tumor is like watering a houseplant with a fire hose—too much water kills the plant, just as too much chemotherapy and radiation kills the patient before it kills the tumor.
However, if the gastrointestinal tract remains healthy and functioning, the chances of survival increase exponentially, said Jian-Guo Geng, associate professor at the University of Michigan School of Dentistry. Recently, Geng’s lab discovered a biological mechanism that preserves the gastrointestinal tracts in mice who were delivered lethal doses of chemotherapy.
The findings, which will appear in the journal Nature, could revolutionize cancer therapy, Geng said. He emphasized that this had not yet been tested in humans, and right now there’s no way to know if people will respond similarly.
“All tumors from different tissues and organs can be killed by high doses of chemotherapy and radiation, but the current challenge for treating the later-staged metastasized cancer is that you actually kill the host before you kill the tumor.
“It’s our belief that this could eventually cure later-staged metastasized cancer. People will not die from cancer, if our prediction is true,” said Geng. “We cannot know this yet, but in mice it has shown promise. Years down the road, we may have a way to make humans tolerate lethal doses of chemotherapy and radiotherapy. In this way, the later-staged, metastasized cancer can be eradicated by increased doses of chemotherapy and radiation.”
Geng’s lab found that when certain proteins bind with a specific molecule on intestinal stem cells, it revs intestinal stem cells into overdrive for intestinal regeneration and repair in mice. Stem cells naturally heal damaged organs and tissues, but so-called “normal” amounts of stem cells in the intestine simply cannot keep up with the wreckage left behind by the lethal doses of chemotherapy and radiation required to successfully treat late-stage tumors.
However, the phalanx of extra stem cells protect the intestine and gastrointestinal tract, which allows the ingestion of nutrients so the body can perform other critical functions and the bacterial toxins in the intestine are prevented from entering the blood circulation, Geng said.
In the future, if the findings are tested in humans and show promise, these factors could give human cancer patients just enough of an extra edge to survive the stronger doses of chemotherapy and radiation, until the tumor or tumors are eradicated.
Geng stressed that even if the findings do show promise in humans, it could take a decade or longer before an application becomes available to use on people.
In the study, 50-to-75 percent of the mice treated with the molecule survived otherwise lethal doses of chemotherapy. All of the mice that did not receive the molecule died, Geng said.
The Latest on: Cancer therapy
- First molecular test predicts treatment response for kidney cancer on February 19, 2019 at 4:25 pm
Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But immunotherapy is expensive, benefits only a subset of patients and is futile in the ma... […]
- The Search for Targetable Alterations in Pancreatic Cancer on February 19, 2019 at 1:11 pm
There are also other alterations that seem to be predictive for other treatment options that should be explored in the future. And that’s almost 1 out every 5 patients with pancreatic cancer. So it’s ... […]
- The Changing Landscape of Pancreatic Cancer Treatment on February 19, 2019 at 12:39 pm
Davendra Sohal, MD, MPH: We’ve certainly made a lot of progress in advanced pancreatic cancer over the last 5 to 7 years or so. It started with FOLFIRINOX, the triple-drug regimen of 5-fluorouracil, i... […]
- Cancer Gene Therapy Market 2019 Global Outlook and Increase, Augmentation by 2025 on February 19, 2019 at 12:02 pm
Feb 19, 2019 (Heraldkeeper via COMTEX) -- “Global Cancer Gene Therapy Market (By Types, By Applications, By Leading Regions and Crucial Players) by Crystal Market Research– Segments Outlook, Business ... […]
- US charity opens cancer ward for children in Gaza on February 19, 2019 at 10:38 am
Children with leukemia and thalassemia, comprising 80 percent of young cancer patients, will now be treated in Gaza ... Cases requiring bone marrow transplants, radiation therapy and nuclear medicine ... […]
- Using anti-cancer immunotherapy to fight HIV on February 19, 2019 at 8:20 am
"We identified the mechanism by which anti-cancer immunotherapy 'awakens' the virus from its hiding places and reduces the size of HIV reservoirs in people on triple therapy. Although most of our ... […]
- Why Do Only Eight Percent Of Cancer Patients In The U.S. Participate In Clinical Trials? on February 19, 2019 at 8:00 am
but also slows down the progress of cancer research. Trials that miss or are slow in getting to their recruitment targets often take longer to complete and make it more difficult for researchers to dr... […]
- Metastatic Prostate Cancer: Symptoms, Medications and More on February 19, 2019 at 7:12 am
Some patients may need a catheter inserted into their urethra, on a temporary or permanent basis, depending on how they respond to treatment. Stage 4 prostate cancer can also spread to lymph nodes ... […]
- Gastric Acid Suppression & Oral Cancer Therapy Should Not Mix on February 19, 2019 at 5:40 am
As many as 50% of patients receiving cancer therapy take gastric acid suppressants (GAS), such as proton pump inhibitors, for medical problems such as gastric ulcers and acid reflux, but a new analysi... […]
- Researchers identify a very early marker of cardiac damage triggered by cancer treatment on February 19, 2019 at 4:13 am
Every year, 4 million new cases of cancer are diagnosed in Europe. Advances in cancer treatment sometimes come at the cost of major adverse effects, and one of the most prominent is cardiotoxicity. […]
via Google News and Bing News